Alvotech enters into commercialization agreement with Polifarma for proposed biosimilar to Eylea® (aflibercept)
Polifarma will commercialize AVT06, a proposed biosimilar to Eylea® , in Turkey Alvotech , a global biotech company specializing in the development and manufacture of biosimilar medicines... | May 10, 2023
Source: marketscreener.com